Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Eucrates Biomedical Acquisition Corp. (EUCRU)

    Price:

    10.02 USD

    ( - -0.07 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    EUCRU
    Name
    Eucrates Biomedical Acquisition Corp.
    Industry
    Shell Companies
    Sector
    Financial Services
    Price
    10.020
    Market Cap
    47.257M
    Enterprise value
    29.801M
    Currency
    USD
    Ceo
    Parag Phoolchand Saxena MBA, MS
    Full Time Employees
    Website
    Ipo Date
    2020-10-06
    City
    New York City
    Address
    250 West 55th Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Churchill Capital Corp X

    VALUE SCORE:

    7

    Symbol
    CCCX
    Market Cap
    773.214M
    Industry
    Shell Companies
    Sector
    Financial Services

    2nd position

    Range Capital Acquisition Corp.

    VALUE SCORE:

    10

    Symbol
    RANGU
    Market Cap
    166.790M
    Industry
    Shell Companies
    Sector
    Financial Services

    The best

    M3-Brigade Acquisition V Corp. Units

    VALUE SCORE:

    10

    Symbol
    MBAVU
    Market Cap
    255.000M
    Industry
    Shell Companies
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    5.401
    P/S
    0
    P/B
    3.504
    Debt/Equity
    0.007
    EV/FCF
    -67.064
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    0.185
    Debt/assets
    0.005
    FUNDAMENTALS
    Net debt/ebidta
    -0.016
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    0.444
    Debt to market cap
    0.001
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    0.054
    P/CF
    -47.453
    P/FCF
    -66.999
    RoA %
    44.356
    RoIC %
    -12.879
    Gross Profit Margin %
    0
    Quick Ratio
    2.029
    Current Ratio
    2.029
    Net Profit Margin %
    0
    Net-Net
    2.827
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.212
    Revenue per share
    0
    Net income per share
    1.859
    Operating cash flow per share
    -0.212
    Free cash flow per share
    -0.212
    Cash per share
    4.153
    Book value per share
    2.865
    Tangible book value per share
    2.865
    Shareholders equity per share
    2.865
    Interest debt per share
    0.020
    TECHNICAL
    52 weeks high
    10.630
    52 weeks low
    9.760
    Current trading session High
    10.020
    Current trading session Low
    10.010
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -13.054

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    184.267
    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    -208.32205%
    P/E
    -49.091

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Financial - Capital Markets
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.377

    No data to display

    logo

    Country
    CN
    Sector
    Technology
    Industry
    Hardware, Equipment & Parts
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0.410
    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    28.849

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -990.143

    No data to display

    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0

    No data to display

    logo

    Country
    US
    Sector
    Energy
    Industry
    Solar
    Dividend yield
    0%
    Payout Ratio
    -6505.857%
    P/E
    -0.002
    DESCRIPTION

    Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

    NEWS